Mitigate delays...after missing dates" I have been continually inspired by the countless examples of our teams finding creative and agile ways to virtualize our organization, continue to deliver high quality work and carry out our important mission for patients with diseases with high unmet medical needs,” said Kenneth Galbraith, Liminal BioSciences’ Chief Executive Officer. “Due to this, we have been able to mitigate delays in the timing of expected key milestones for 2020 including the resubmission of our biologics licensing application (BLA) with the United States Food and Drug Administration (FDA) for Ryplazim® (plasminogen), or Ryplazim"
LOL, "mitigate delays in the timing of expected key milestones for 2020". Does the CEO realize he just missed a second BLA submission date in July?